NASDAQ · AZTA

Azenta, Inc.

$27.52 +$0.15 (+0.55%) 1D After hours

Key Metrics

$1.26B
Market cap
P/E · TTM
$596.33M
Revenue · TTM
−$178.20M
Net income
EPS · TTM $-3.87
Dividend yield
Free cash flow $30.05M
Beta · 1Y 1.55
EBITDA · TTM
Gross margin 43.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 15
    From its Jan 29 high, the share price fell 59%.

    Peak close $39.00 on Jan 29; trough close $16.02 on May 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -59%
  • May 6
    The stock moved -25.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6
  • Feb 4
    The stock moved -22.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.26B
Enterprise value
Shares outstanding46.1M
52-wk range$15.93 – $41.73
Avg volume · 20D743.5K
Net cash
Book value / share$33.80
IndustrySpecial Industry Machinery, Nec
ExchangeNASDAQ
About Azenta, Inc.
IPO dateFeb 1, 1995
Employees2900

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.12
P/FCF41.99
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 43.8%
Operating -25.2%
Net -29.9%
FCF 5.0%
ROE / ROIC -10.7% · -9.4%

Financial Health

Current ratio2.83
Quick ratio2.52
Debt / equity
Debt / EBITDA
Net cash
Working capital$469.79M

Cash Flow · TTM

Operating CF $62.34M
Capex −$32.29M
Free cash flow $30.05M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

3.4
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings